Published in Gene Therapy Weekly, December 14th, 1998
S. Ellouk-Achard and colleagues from the Laboratoire de Genetique Moleculaire, France, developed a gene therapy strategy based on the observation that IGF-I is necessary for the acquisition and maintenance of the transformed phenotype in hepatocarcinoma ("Induction of Apoptosis in Rat Hepatocarcinoma Cells by Expression of IGF-I antisense cDNA," J. Hepatol., November 1998;29(5):807-18).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.